Proof of Usefulness Report

NexaReg

Analysis completed on 2/13/2026

+8
Proof of Usefulness Score
You're In Business

The project faces critical red flags. Most notably, the UK entity 'Nexareg Global Ltd' filed for voluntary strike-off in January 2026, indicating the business may be closing or has failed. Additionally, the submission contains objectively false claims regarding traction ('most people have used my product') and audience ('everyone'), which are impossible for a specialized MedTech B2B compliance tool. The financial metric is cited as 'marketcap' rather than revenue, further reducing credibility. While the problem space (MedTech compliance) is high-value, the project's execution appears to have stalled or failed.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+20
Audience Reach Impact+0
Technical Innovation+20
Evidence Of Traction+0
Market Timing Relevance+60
Functional Completeness+10
Subtotal+7.5
Usefulness Multiplierx1.07
Final Score+8

Project Details

Project URL
nexareg.com
Description
End-to-end compliance solution built for MedTech, BioTech and Pharma, designed to streamline submissions, ensure traceability, and eliminate regulatory blind spots. NexaReg automates manual workflows, maps requirements across your documentation, and flags gaps early, while converting raw files into standardised, audit-ready templates tailored to your regulatory pathway. QA/RA teams stay consistently compliant and ready for audits, with faster, higher-quality outputs.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline